Pulmonary Arterial Hypertension
📧 Sign up to get email alerts when something new happens for Pulmonary Arterial Hypertension.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-07-28Clinical Trial Results: Utility of At-home Monitoring of Exercise Capacity by App-based 6-minute Walk Test [NA]
Results of a completed clinical trial evaluating at-home monitoring of exercise capacity using an app-based 6-minute walk test in patients w…
-
CLINICAL_TRIALS trial_result · 2026-07-06Clinical Trial Results: Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects [Phase 3]
Phase 3 trial evaluating ralinepag on exercise capacity in pulmonary arterial hypertension; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2026-07-02Clinical Trial Results: A Study to Investigate the Safety and Efficacy of KER-012 in Combination With Background Therapy in Adult Participants With Pulmonary Arterial Hypertension (PAH) (TROPOS Study). [Phase 2]
A Phase 2 trial evaluating KER-012 in combination with background therapy for adult pulmonary arterial hypertension was terminated; results …
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Effects of Riociguat on RIght VEntricular Size and Function in PAH and CTEPH [Phase 4]
Phase 4 trial results on riociguat evaluating effects on right ventricular size and function in patients with primary pulmonary arterial hyp…
-
CLINICAL_TRIALS trial_result · 2026-06-17Clinical Trial Results: Vardenafil Inhaled for Pulmonary Arterial Hypertension PRN Phase 2B Study [Phase 2]
Phase 2B trial results of inhaled vardenafil for pulmonary arterial hypertension have been completed and results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension [Phase 3]
Phase 3 outcome study evaluating a 75 mg dose of macitentan in patients with pulmonary arterial hypertension; status active but not recruiti…
-
CLINICAL_TRIALS trial_result · 2026-06-05Clinical Trial Update: A Study of Selexipag as Add-On Treatment to Standard of Care in Children With Pulmonary Arterial Hypertension [Phase 3]
Phase 3 trial investigating selexipag as add-on therapy to standard of care in children with pulmonary arterial hypertension; status ACTIVE_…
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) [Phase 3]
Phase 3 trial update on seralutinib in adults with pulmonary arterial hypertension reports efficacy and safety results.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT) [Phase 3]
Open-label extension study update for seralutinib in adults with pulmonary arterial hypertension (PAH) continuing from a Phase 3 program.
-
CLINICAL_TRIALS trial_result · 2026-04-27Clinical Trial Results: Study of Sotatercept in Newly Diagnosed Intermediate- and High-Risk PAH Participants (MK-7962-005/A011-13) [Phase 3]
Phase 3 trial of sotatercept (MK-7962) in newly diagnosed intermediate- and high-risk pulmonary arterial hypertension was terminated with re…
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008) [Phase 2]
A Phase 2 study is evaluating Sotatercept (MK-7962) in children with pulmonary arterial hypertension. The trial is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: Sotatercept on Central Cardiopulmonary Performance and Peripheral Oxygen Transport During Exercise in Pulmonary Arterial Hypertension [Phase 4]
This Phase 4 clinical trial update summarizes results from a study of sotatercept assessing central cardiopulmonary performance and peripher…
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients [Phase 3]
A Phase 3 trial evaluating Ralinepag for pulmonary arterial hypertension has completed; the update covers the study status and its efficacy …
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: An Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) for Pulmonary Arterial Hypertension (PAH) [Phase 2, Phase 3]
This clinical trial update describes an extension study of Treprostinil Palmitil Inhalation Powder (TPIP) for pulmonary arterial hypertensio…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: The Effects of Drug Candidate CS1 on Lung Structure and Function Utilizing FRI
A completed clinical trial evaluating the effects of drug candidate CS1 on lung structure and function using FRI in pulmonary arterial hyper…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA) [Phase 3]
Phase 3 PROSERA trial evaluating Seralutinib for pulmonary arterial hypertension has completed. The update covers efficacy and safety in adu…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: Open-label Extension Study of GB002 in Adult Subjects With Pulmonary Arterial Hypertension (PAH) [Phase 2]
Open-label extension study of GB002 in adults with pulmonary arterial hypertension is ongoing, with the trial status listed as ACTIVE_NOT_RE…
-
CLINICAL_TRIALS trial_result · 2026-04-07Clinical Trial Update: Endothelial Cell Dysfunction in Pulmonary Hypertension [Phase 1]
Phase 1 clinical trial investigating endothelial cell dysfunction in pulmonary hypertension has completed. The study focused on secondary pu…
-
CLINICAL_TRIALS trial_result · 2026-04-06Clinical Trial Update: A Dose Escalation Study to Evaluate the Effect of RT234 in Subjects With Pulmonary Arterial Hypertension [Phase 2]
This is a Phase 2 dose-escalation study evaluating RT234 in subjects with pulmonary arterial hypertension. The study status is completed.
-
CLINICAL_TRIALS trial_result · 2026-04-03Clinical Trial Update: Assessment of Right Ventricular Function by Cardiac MRI in Patients With Pulmonary Arterial Hypertension (IRMA)
A clinical trial evaluating right ventricular function in pulmonary arterial hypertension using cardiac MRI has completed, with the sponsor …
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: A Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Treprostinil Palmitil Inhalation Powder in Participants With Pulmonary Arterial Hypertension [Phase 2]
This document reports the completion of a Phase 2 clinical trial evaluating the efficacy, safety and pharmacokinetics of treprostinil palmit…
-
CLINICAL_TRIALS trial_result · 2026-03-27Clinical Trial Update: Auto-immunity and Pulmonary Arterial Hypertension [NA]
Status update indicating a trial on auto-immunity and pulmonary arterial hypertension sponsored by Assistance Publique - Hôpitaux de Paris i…
-
CLINICAL_TRIALS trial_result · 2026-03-25Clinical Trial Update: Endothelial Cell Activation and Total Pulmonary Resistance in PAH [NA]
A clinical trial update from Imperial College London on endothelial cell activation and total pulmonary resistance in pulmonary arterial hyp…
-
CLINICAL_TRIALS trial_result · 2026-03-09Clinical Trial Update: Safety and Impact of Low Resistance Exercise Training on Quality of Life in Pulmonary Arterial Hypertension [NA]
A clinical trial update examining the safety and impact of low resistance exercise training on quality of life in people with pulmonary arte…
-
CLINICAL_TRIALS trial_result · 2026-02-24Clinical Trial Update: 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH) [Phase 2]
Phase 2 clinical trial examining Xenon-129 MRI as a biomarker for diagnosis and treatment response in pulmonary arterial hypertension, curre…